Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04657172 · ClinicalTrials.gov registry record · Phase 3
Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults
A Phase 3 study of Presbyopia, sponsored by Eyenovia.
- Completed
- Registry status
- Phase 3
- Development phase
- 84
- Enrollment target
- 9
- Study locations
NCT04657172 is a Phase 3 study of Presbyopia that has completed, run by Eyenovia. The registered enrollment target is 84 participants, below the 268-participant average among 38 other Presbyopia trials with a reported enrollment target (69% lower). The trial reports 9 study locations across 7 states.
The verdict
NCT04657172, a Phase 3 study of Presbyopia, has completed, sponsored by Eyenovia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 84 participants
- Enrollment target
- 9
- Study locations
Study Summary
Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting study inclusion/exclusion criteria are scheduled for 3 treatment visits. At each treatment visit, 1 of the 3 study solutions is self-administered to both eyes. Afterwards, efficacy and safety assessments are performed over a 3-hour period.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pilocarpine Ophthalmic
Study Locations (9)
California
- VISION-1 Study Site #21 - Azusa
- VISION-1 Study Site #52 - Newport Beach
North Carolina
- VISION-1 Study Site #17 - High Point
- VISION-1 Study Site #22 - Raleigh
Colorado
- VISION-1 Study Site #54 - Fort Collins
Florida
- VISION-1 Study Site #53 - Orlando
New York
- VISION-1 Study Site #50 - New York
Pennsylvania
- VISION-1 Study Site #51 - Cranberry Township
Texas
- VISION-1 Study Site #03 - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2021-03-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04657172
The ClinicalTrials.gov registry entry for NCT04657172 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 268-participant average among 38 other Presbyopia trials with a reported enrollment target (69% lower). The listed sponsor is Eyenovia, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04657172 reports 9 study locations spanning 7 distinct geographic areas - top geographies include California, North Carolina, Colorado.
Frequently Asked Questions
What is clinical trial NCT04657172 about?
NCT04657172 is a clinical study titled "Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults". Volunteer participants are evaluated for eligibility during a Screening Visit; those meeting study inclusion/exclusion criteria are scheduled for 3 treatment visits. At each treatment visit, 1 of the 3 study solutions is self-administered to both eyes. Afterwards, efficacy and safety assessments are...
What is the current status of trial NCT04657172?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 84 participants. The study started on 2020-12-15. Estimated completion is 2021-03-26.
What conditions does trial NCT04657172 study?
This clinical trial studies the following conditions: Presbyopia.
What interventions are being tested in trial NCT04657172?
The interventions under investigation include: Placebo (DRUG), Pilocarpine Ophthalmic (DRUG).
Who is sponsoring clinical trial NCT04657172?
This trial is sponsored by Eyenovia, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04657172 being conducted?
This trial has 9 study locations across California, Colorado, Florida, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Presbyopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase III Presbyopia Correction Using the VIS Opti-K™ System
RECRUITING · Phase 3
-
Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia
COMPLETED · Phase 3
-
Safety & Efficacy of Pilocarpine Ophthalmic Spray for Temporary Improvement of Near Vision in Presbyopic Adults
COMPLETED · Phase 3
-
Phase 3 Safety Study for the Treatment of Presbyopia Subjects
COMPLETED · Phase 3
-
An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)
COMPLETED · Phase 3
-
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.